{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T20:09:33Z","timestamp":1787083773704,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,27]]},"DOI":"10.7759\/cureus.88856","type":"journal-article","created":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T16:56:36Z","timestamp":1753635396000},"source":"Crossref","is-referenced-by-count":1,"title":["Correlation Between Hepatic and Splenic Steatosis Assessed by Transient Elastography in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease"],"prefix":"10.7759","author":[{"given":"Abeer","family":"Altaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaigham","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Qadeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehreen","family":"Siyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023, 78:1966-86. 10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14813","article-title":"Non-alcoholic fatty liver disease in Asia: How is it different from the West?","volume":"34","author":"Wong GL","year":"2019","unstructured":"Wong GL, Wong VW. Non-alcoholic fatty liver disease in Asia: How is it different from the West?. J Gastroenterol Hepatol. 2019, 34:1267-8. 10.1111\/jgh.14813","journal-title":"J Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.07.033","article-title":"NAFLD and liver transplantation: current burden and expected challenges","volume":"65","author":"Pais R","year":"2016","unstructured":"Pais R, Barritt AS 4th, Calmus Y, et al.. NAFLD and liver transplantation: current burden and expected challenges. J Hepatol. 2016, 65:1245-57. 10.1016\/j.jhep.2016.07.033","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States.","volume":"19","author":"Younossi ZM","year":"2021","unstructured":"Younossi ZM, Stepanova M, Ong J, et al.. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States.. Clin Gastroenterol Hepatol. 2021, 19:580-9.e5. 10.1016\/j.cgh.2020.05.064","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8060868","article-title":"A systematic review of NAFLD-associated extrahepatic disorders in youths","volume":"8","author":"Pacifico L","year":"2019","unstructured":"Pacifico L, Perla FM, Roggini M, Andreoli G, D'Avanzo M, Chiesa C. A systematic review of NAFLD-associated extrahepatic disorders in youths. J Clin Med. 2019, 8:868. 10.3390\/jcm8060868","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne CD","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015, 62:S47-64. 10.1016\/j.jhep.2014.12.012","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1023\/a:1005446418589","article-title":"Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen","volume":"45","author":"Tsushima Y","year":"2000","unstructured":"Tsushima Y, Endo K. Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci. 2000, 45:196-200. 10.1023\/a:1005446418589","journal-title":"Dig Dis Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam M","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al.. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020, 73:202-9. 10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15561","article-title":"High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease","volume":"43","author":"Odriozola A","year":"2023","unstructured":"Odriozola A, Puente \u00c1, Cuadrado A, et al.. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease. Liver Int. 2023, 43:1446-57. 10.1111\/liv.15561","journal-title":"Liver Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","unstructured":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021, 75.659-89. 10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03160-8","article-title":"Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients","volume":"24","author":"Wang M","year":"2024","unstructured":"Wang M, Tang S, Li G, et al.. Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients. BMC Gastroenterol. 2024, 24:81. 10.1186\/s12876-024-03160-8","journal-title":"BMC Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong MJ","year":"2014","unstructured":"Armstrong MJ, Adams LA, Canbay A, Syn WK. Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2014, 59:1174-97. 10.1002\/hep.26717","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.10.030","article-title":"Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis","volume":"78","author":"Zhang X","year":"2023","unstructured":"Zhang X, Song J, Zhang Y, et al.. Baveno VII algorithm outperformed other models in ruling out high-risk varices in individuals with HBV-related cirrhosis. J Hepatol. 2023, 78:574-83. 10.1016\/j.jhep.2022.10.030","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino G","year":"2021","unstructured":"Tarantino G, Citro V, Balsano C. Liver-spleen axis in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2021, 15:759-69. 10.1080\/17474124.2021.1914587","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07617.x","article-title":"A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced hypothalamic inflammation","volume":"120","author":"Gotoh K","year":"2012","unstructured":"Gotoh K, Inoue M, Masaki T, et al.. A novel anti-inflammatory role for spleen-derived interleukin-10 in obesity-induced hypothalamic inflammation. J Neurochem. 2012, 120:752-64. 10.1111\/j.1471-4159.2011.07617.x","journal-title":"J Neurochem"},{"key":"ref17","article-title":"Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in nonalcoholic steatohepatitis with type 2 diabetes?","volume":"112","author":"Kocabay G","year":"2011","unstructured":"Kocabay G, Telci A, Tutuncu Y, et al.. Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in nonalcoholic steatohepatitis with type 2 diabetes?. Bratisl Lek Listy. 2011, 112:626-9.","journal-title":"Bratisl Lek Listy"},{"key":"ref18","article-title":"Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parameters","volume":"30","author":"El-Aziz RA","year":"2018","unstructured":"El-Aziz RA, Naguib M, Rashed LA. Spleen size in patients with metabolic syndrome and its relation to metabolic and inflammatory parameters. Egypt J Intern Med. 2018, 30:78-82.","journal-title":"Egypt J Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.116.139188","article-title":"Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients","volume":"105","author":"Gallagher D","year":"2017","unstructured":"Gallagher D, Kelley DE, Thornton J, et al.. Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients. Am J Clin Nutr. 2017, 105:78-84. 10.3945\/ajcn.116.139188","journal-title":"Am J Clin Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100575","article-title":"Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701)","volume":"4","author":"Yu Q","year":"2022","unstructured":"Yu Q, Xu C, Li Q, et al.. Spleen volume-based non-invasive tool for predicting hepatic decompensation in people with compensated cirrhosis (CHESS1701). JHEP Rep. 2022, 4:100575. 10.1016\/j.jhepr.2022.100575","journal-title":"JHEP Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0971-3026.143897","article-title":"Preoperative CT evaluation of potential donors in living donor liver transplantation","volume":"24","author":"Vohra S","year":"2014","unstructured":"Vohra S, Goyal N, Gupta S. Preoperative CT evaluation of potential donors in living donor liver transplantation. Indian J Radiol Imaging. 2014, 24:350-9. 10.4103\/0971-3026.143897","journal-title":"Indian J Radiol Imaging"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346370-correlation-between-hepatic-and-splenic-steatosis-assessed-by-transient-elastography-in-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T16:56:37Z","timestamp":1753635397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346370-correlation-between-hepatic-and-splenic-steatosis-assessed-by-transient-elastography-in-patients-with-metabolic-dysfunction-associated-steatotic-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,27]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.88856","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,27]]}}}